News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
GV 2017 GP, L.L.C.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
11/08/2022 |
4
| GV 2017 GP, L.L.C. (Member of 10% Group) has filed a Form 4 on Verve Therapeutics, Inc.
Txns:
| Disposed of 48,583 shares
@ $0 Sold 47,690 shares
@ $31.118, valued at
$1.5M
Sold 651 shares
@ $31.9905, valued at
$20.8k
Sold 242 shares
@ $32.9, valued at
$8k
Sold 47,690 shares
@ $31.118, valued at
$1.5M
Sold 650 shares
@ $31.9905, valued at
$20.8k
Sold 243 shares
@ $32.9, valued at
$8k
|
|
11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/06/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
06/22/2021 |
4
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 4 on Verve Therapeutics, Inc.
Txns:
| Converted 6,320,905 shares
@ $0 Converted 58,528,428 preferred shares
@ $0 |
|
06/16/2021 |
3
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 3 on Verve Therapeutics, Inc. |
02/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/11/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
03/19/2018 |
4
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 4 on Arcus Biosciences, Inc.
Txns:
| Converted 1,924,474 shares
@ $0 Converted 1,924,474 convertible preferred
@ $0 |
|
03/14/2018 |
3
| GV 2017 GP, L.L.C. (10% Owner) has filed a Form 3 on Arcus Biosciences, Inc. |
|
|